ChromaDex Sets Second Quarter 2018 Financial Results on Thursday, August 9, 2018
02 août 2018 06h30 HE
|
ChromaDex Corporation
IRVINE, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship...
Fourth Published Clinical Trial Confirms Long-Term Safety of NIAGEN® Supplementation at High Doses and Shows Potential for Improvement in Liver Health
11 juil. 2018 06h30 HE
|
ChromaDex Corporation
IRVINE, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that...
TRU NIAGEN® to be featured at the American Association of Naturopathic Physicians Annual Convention and the 2018 Healthy Aging Summit
09 juil. 2018 06h30 HE
|
ChromaDex Corporation
IRVINE, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that it...
ChromaDex added to membership of US small-cap Russell 2000® Index
25 juin 2018 06h30 HE
|
ChromaDex Corporation
IRVINE, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship...
ChromaDex Appoints Lisa Bratkovich as Chief Marketing Officer
04 juin 2018 06h30 HE
|
ChromaDex Corporation
IRVINE, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that it...
TRU NIAGEN® to be featured at the American Society for Nutrition's Annual Meeting
29 mai 2018 06h30 HE
|
ChromaDex Corporation
IRVINE, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that it...
ChromaDex Appoints Nobel Laureate, Professor Sir John Walker, to the Scientific Advisory Board
14 mai 2018 06h30 HE
|
ChromaDex Corporation
IRVINE, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that it...
ChromaDex Corporation Reports First Quarter 2018 Financial Results
10 mai 2018 16h05 HE
|
ChromaDex Corporation
IRVINE, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ:CDXC), a science-based, integrated nutraceutical company devoted to improving the way people age, announced today first...
ChromaDex Sets First Quarter 2018 Financial Results on Thursday, May 10, 2018
03 mai 2018 06h30 HE
|
ChromaDex Corporation
IRVINE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, will report financial...
ChromaDex Remains Confident Amidst Inter Partes Review (IPR) Procedural Changes
01 mai 2018 06h30 HE
|
ChromaDex Corporation
IRVINE, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that the...